← FDA Drug Approvals (Drugs@FDA)
NDA206451
NDA · New Drug Application · Sponsor: CIPLA · Approved 2017-10-27
Drug application
- FDA Application #
NDA206451- Application type
- New Drug Application
- Brand name
- —
- Generic name
- —
- Active ingredients
- —
- Dosage form
- —
- Route
- —
- Marketing status
- —
- Sponsor
- CIPLA
- First approval
- 2017-10-27
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown